Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
Clinical trial NCT03406078 · COMPLETED
Trial details
- NCT number
- NCT03406078
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2020-09-25
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.